Dichloroacetate / DCA Metabolic Therapy

DCA is promoted as a metabolic therapy targeting pyruvate dehydrogenase kinase and the Warburg effect. Dichloroacetate has preclinical and early clinical oncology interest through metabolic targeting. It is also promoted online as an alternative cancer therapy. Human clinical use remains investigational, with neuropathy and safety issues requiring clinician oversight.